About Covis Pharma
Covis Pharma is a company based in Zug (Switzerland) founded in 2011 was acquired by Azurity Pharmaceuticals in March 2025.. The company has 10 employees as of December 31, 2020. Covis Pharma has completed 1 acquisition, including AMAG Pharma. Covis Pharma offers products and services including Alvesco, Duaklir, Feraheme, and Tudorza.
- Headquarter Zug, Switzerland
- Employees 10 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amag Pharmaceuticals Inc.
-
Annual Revenue
$474 M-4as on Dec 31, 2018
-
Net Profit
$-65.76 M67as on Dec 31, 2018
-
EBITDA
$-47.05 M85as on Dec 31, 2018
-
Latest Funding Round
$350 M (USD), Debt – Conventional
Dec 13, 2018
-
Investors
Apollo Global Management
& 2 more
-
Employee Count
10
as on Dec 31, 2020
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Covis Pharma
Covis Pharma offers a comprehensive portfolio of products and services, including Alvesco, Duaklir, Feraheme, and Tudorza. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats asthma and respiratory conditions through inhalation therapy.
Manages chronic obstructive pulmonary disease symptoms effectively.
Provides iron treatment for anemia in chronic kidney disease patients.
Controls symptoms of chronic bronchitis and emphysema conditions.
Unlock access to complete
Funding Insights of Covis Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Debt – Conventional — $350.0M
-
First Round
First Round
(13 Dec 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Debt – Conventional - Covis Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Covis Pharma
Covis Pharma has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Apollo Global Management, Azurity Pharmaceuticals and Cerberus Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Buyouts are targeted through private equity investments by the firm.
|
Founded Year | Domain | Location | |
|
Private equity and debt firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Generic drugs are manufactured by Azurity Pharmaceuticals in the US.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Covis Pharma
Covis Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AMAG Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of anemia based products and imaging agents for cancer and CVD diagnosis
|
1981 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Covis Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Covis Pharma Comparisons
Competitors of Covis Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Covis Pharma
Frequently Asked Questions about Covis Pharma
When was Covis Pharma founded?
Covis Pharma was founded in 2011 and raised its 1st funding round 7 years after it was founded.
Where is Covis Pharma located?
Covis Pharma is headquartered in Zug, Switzerland. It is registered at Zug, Zug, Switzerland.
How many employees does Covis Pharma have?
As of Dec 31, 2020, the latest employee count at Covis Pharma is 10.
What is the annual revenue of Covis Pharma?
Annual revenue of Covis Pharma is $474M as on Dec 31, 2018.
What does Covis Pharma do?
Covis Pharma was founded in 2011 in Zug, Switzerland, as a pharmaceutical company focused on the sector of treatments for severe health issues. A portfolio of five products, including Altoprev, Betapace, Betapace AF, Rilutek for amyotrophic lateral sclerosis, and Lanoxin injection for moderate heart failure, is maintained. Operations involve marketing these therapies internationally. In April 2015, 18 products were acquired by Concordia Healthcare Group for 1.2 billion.
What products or services does Covis Pharma offer?
Covis Pharma offers Alvesco, Duaklir, Feraheme, and Tudorza.
How many acquisitions has Covis Pharma made?
Covis Pharma has made 1 acquisition, including AMAG Pharma.
Who are Covis Pharma's investors?
Covis Pharma has 3 investors. Key investors include Apollo Global Management, Azurity Pharmaceuticals, and Cerberus Capital Management.